Nirupama Mulherkar

1.9k total citations · 1 hit paper
11 papers, 1.4k citations indexed

About

Nirupama Mulherkar is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Nirupama Mulherkar has authored 11 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Nirupama Mulherkar's work include Viral Infections and Outbreaks Research (5 papers), Viral Infections and Vectors (4 papers) and Cell death mechanisms and regulation (3 papers). Nirupama Mulherkar is often cited by papers focused on Viral Infections and Outbreaks Research (5 papers), Viral Infections and Vectors (4 papers) and Cell death mechanisms and regulation (3 papers). Nirupama Mulherkar collaborates with scholars based in United States, India and Japan. Nirupama Mulherkar's co-authors include Kartik Chandran, Sean P. J. Whelan, Anthony Wong, Matthijs Raaben, Gordon Ruthel, John M. Dye, Jan E. Carette, Thijn R. Brummelkamp, Philip J. Kranzusch and Ana I. Kuehne and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Cancer Research.

In The Last Decade

Nirupama Mulherkar

11 papers receiving 1.4k citations

Hit Papers

Ebola virus entry requires the cholesterol transporter Ni... 2011 2026 2016 2021 2011 250 500 750

Peers

Nirupama Mulherkar
Jillian M. Rojek United States
Eugene V. Ravkov United States
Birte Kalveram United States
Tuija Pöyry United Kingdom
Abhilash I. Chiramel United States
Emily Burke United States
Elita Avota Germany
Jillian M. Rojek United States
Nirupama Mulherkar
Citations per year, relative to Nirupama Mulherkar Nirupama Mulherkar (= 1×) peers Jillian M. Rojek

Countries citing papers authored by Nirupama Mulherkar

Since Specialization
Citations

This map shows the geographic impact of Nirupama Mulherkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nirupama Mulherkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nirupama Mulherkar more than expected).

Fields of papers citing papers by Nirupama Mulherkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nirupama Mulherkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nirupama Mulherkar. The network helps show where Nirupama Mulherkar may publish in the future.

Co-authorship network of co-authors of Nirupama Mulherkar

This figure shows the co-authorship network connecting the top 25 collaborators of Nirupama Mulherkar. A scholar is included among the top collaborators of Nirupama Mulherkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nirupama Mulherkar. Nirupama Mulherkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Mulherkar, Nirupama & David T. Scadden. (2021). What is the role of the bone marrow microenvironment in AML?. Best Practice & Research Clinical Haematology. 34(4). 101328–101328. 5 indexed citations
2.
Bhattacharyya, Suchita, Nirupama Mulherkar, & Kartik Chandran. (2012). Endocytic Pathways Involved in Filovirus Entry: Advances, Implications and Future Directions. Viruses. 4(12). 3647–3664. 15 indexed citations
3.
Carette, Jan E., Matthijs Raaben, Anthony Wong, et al.. (2011). Ebola virus entry requires the cholesterol transporter Niemann–Pick C1. Nature. 477(7364). 340–343. 972 indexed citations breakdown →
4.
Martinez, Osvaldo, et al.. (2011). Impact of Ebola Mucin-Like Domain on Antiglycoprotein Antibody Responses Induced by Ebola Virus-Like Particles. The Journal of Infectious Diseases. 204(suppl 3). S825–S832. 45 indexed citations
5.
Mulherkar, Nirupama, Matthijs Raaben, Juan Carlos de la Torre, Sean P. J. Whelan, & Kartik Chandran. (2011). The Ebola virus glycoprotein mediates entry via a non-classical dynamin-dependent macropinocytic pathway. Virology. 419(2). 72–83. 104 indexed citations
6.
Mulherkar, Nirupama, et al.. (2009). MADD, a Splice Variant of IG20, Is Indispensable for MAPK Activation and Protection against Apoptosis upon Tumor Necrosis Factor-α Treatment. Journal of Biological Chemistry. 284(20). 13533–13541. 39 indexed citations
7.
8.
Sheng, Jian Rong, et al.. (2008). Regulation of Apoptosis and Caspase-8 Expression in Neuroblastoma Cells by Isoforms of the IG20 Gene. Cancer Research. 68(18). 7352–7361. 22 indexed citations
9.
Prabhakar, Bellur S., Nirupama Mulherkar, & Kanteti V. Prasad. (2008). Role of IG20 Splice Variants in TRAIL Resistance. Clinical Cancer Research. 14(2). 347–351. 21 indexed citations
10.
Mulherkar, Nirupama, Kanteti V. Prasad, & Bellur S. Prabhakar. (2007). MADD/DENN Splice Variant of the IG20 Gene Is a Negative Regulator of Caspase-8 Activation. Journal of Biological Chemistry. 282(16). 11715–11721. 31 indexed citations
11.
Mulherkar, Nirupama, et al.. (2006). MADD/DENN splice variant of the IG20 gene is necessary and sufficient for cancer cell survival. Oncogene. 25(47). 6252–6261. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026